HEALTH● LOWJul 10 · Jul 10, 2026, 11:29 AM
GSK partner Hansoh posts late-stage trial win for lung cancer drug in China
Seeking Alpha Tech
A partner of GSK, Hansoh, has successfully completed a late-stage trial for a lung cancer drug in China. This development marks progress in the pharmaceutical industry's efforts to treat lung cancer.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH32m agoWhite House chief of staff Susie Wiles had medical procedure at Mayo ClinicCBS NewsHEALTHBREAKING48m agoOne dead as Taraba records first diphtheria caseVanguard NigeriaHEALTH1h agoShe is 34 years old and received chemotherapy by mistake for more than a decade: "It ruined my life"ClarínHEALTHBREAKING1h agoTaraba Records First Confirmed Diphtheria Case, Patient DiesChannels TV